A novel agonist, phorbol 12-phenylacetate 13-acetate 20-homovanillate, abolishes positive cooperativity of binding by the vanilloid receptor

European Journal of Pharmacology

Volumn 299, Issue 1-3, 1996, Pages 221-228

  Szallasi, Arpad ^a   Acs, Geza ^b   Cravotto, Giancarlo ^c   Blumberg, Peter M ^b   Lundberg, Jan M ^a   Appendino, Giovanni ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Binding cooperativity; Capsaicin; PPAHV (phorbol 12 phenylacetate 13 acetate 20 homovanillate); Resiniferatoxin; Vanilloid rcccptor

Indexed keywords

CAPSAICIN; CAPSAZEPINE; NEW DRUG; PHORBOL 12 PHENYLACETATE 13 ACETATE 20 HOMOVANILLATE; RADIOISOTOPE; RESINIFERATOXIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR AGONIST; VANILLOID RECEPTOR ANTAGONIST;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG SYNTHESIS; FEMALE; MEMBRANE BINDING; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SENSORY NERVE CELL; SPINAL CORD; SPINAL GANGLION;

EID: 0029912155     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00864-0     Document Type: Article

References (37)

1. 45Ca uptake by adult rat dorsal root ganglion neurones, J. Pharmacol. Exp. Ther. 274, 1090.
2. 45Ca uptake and for high affinity binding in cultured rat dorsal root anglion neurones and dorsal root ganglion membranes, Brain Res. (in press).
3. Bevan, S. and J. Szolcsanyi, 1990, Sensory neuron-specific actions of capsaicin: mechanisms and applications, Trends Pharmacol. Sci. 11, 330.
4. Bevan, S., S. Hothi, G. Hughes, I.F. James, H.P. Rang, K. Shah, C.S.J. Walpole and J. Yeats, 1992, Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin, Br. J. Pharmacol. 107, 544.
5. Blumberg, P.M., A. Szallasi and G. Acs, 1993, Resiniferatoxin - an ultrapotent capsaicin analogue, in: Capsaicin in the Study of Pain, ed. J.N. Wood (Academic Press, London) p. 45.
6. Buck, S.H. and T.F. Burks, 1986, The neuropharmacology of capsaicin: review of some recent observations, Pharmacol. Rev. 38, 179.
7. Carter, R.B., 1991, Topical capsaicin in the treatment of cutaneous disorders, Drug Dev. Res. 22, 109.
8. 2) receptors in perfused rat hindlimb, Life Sci. 57, 91.
9. Davis, M.E., T. Akera, T.M. Brody and L. Watson, 1977, Opiate receptor: cooperativity of binding observed in brain slices, Proc. Natl. Acad. Sci. USA 74, 5764.
10. Endrenyi, L., Cs. Fajszi and F.H. Kwong, 1975, Evaluation of Hill slopes and Hill coefficients when the saturation binding or velocity is not known, Eur. J. Biochem. 51, 317.
11. Fels, G., E.K. Wolff and A. Maelicke, 1982, Equilibrium binding of acetylcholine to the membrane-bound acetylcholine receptor, Eur. J. Biochem. 127, 31.
12. Hergenhahn, M., W. Adolph and E. Hecker, 1975, Resiniferatoxin and other esters of novel polyfunctional diterpenes from Euphorbia resinifera and unispina, Tetrahedron Lett. 19, 1595.
13. Holzer, P., 1991, Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons, Pharmacol. Rev. 43, 144.
14. James, I.F., N. Ninkina and J.N. Wood, 1993, The capsaicin receptor, in: Capsaicin in the Study of Pain, ed. J.N. Wood (Academic Press, London) p. 83.
15. Jancso, N., 1968, Desensitization with capsaicin and related acylamides as a tool for studying the function of pain receptors, in: Pharmacology of Pain, eds. K. Lin, D. Armstrong, and E.G. Pardo (Pergamon Press, Oxford) p. 33.
16. Jancso, G., E. Kiraly and A. Jancso-Gabor, 1977, Pharmacologically induced selective degeneration of chemosensitive sensory neurones, Nature (London) 270, 741.
17. Koshland, D.E., G. Nemethy and D. Filmer, 1966, Comparison of experimental binding data and theoretical models in proteins containing subunits, Biochemistry (Washington, DC) 5, 365.
18. Maggi, C.A., 1992, Therapeutic potential of capsaicin-like molecules: studies in animals and humans, Life Sci. 51, 1777.
19. Maggi, C.A., R. Patacchini, M. Tramontana, R. Amann, S. Giuliani and P. Santicioli, 1990, Similarities and differences in the action of resiniferatoxin and capsaicin on central and peripheral endings of primary sensory neurons, Neuroscience 37, 531.
20. McPherson, G.A., 1985, Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC, J. Pharmacol. Methods 14, 213.
21. Monod, J., J. Wyman and J.-P. Changeux, 1965, On the nature of allosteric transitions: a plausible model, J. Mol. Biol. 12, 88.
22. Notides, A.C., N. Lerner and D.E. Hamilton, 1981, Positive cooperativity of the estrogen receptor, Proc. Natl. Acad. Sci. USA 78, 4926.
23. Schiebler, W., L. Lauffer and F. Hucho, 1977, Acetylcholine receptor enriched membranes: acetylcholine binding and excitability after reduction in vitro, FEBS Lett. 81, 39.
24. Schwartz, J.A. and D.F. Skafar, 1993, Ligand-mediated modulation of estrogen receptor conformation by estradiol analogs, Biochemistry (Washington, DC) 32, 10109.
25. Szallasi, A., 1994, The vanilloid (capsaicin) receptor: receptor types and species differences, Gen. Pharmacol. 25, 223.
26. Szallasi, A. and P.M. Blumberg, 1990a, Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes, Brain Res. 524, 111.
27. Szallasi, A. and P.M. Blumberg, 1990b, Resiniferatoxin and analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor, Life Sci. 47, 1399.
28. Szallasi, A. and P.M. Blumberg, 1991, Molecular target size of the vanilloid (capsaicin) receptor in pig dorsal root ganglia, Life Sci. 48, 1863.
29. Szallasi, A. and P.M. Blumberg, 1993a, Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules), Adv. Pharmacol. 24, 123.
30. 3H]Resiniferatoxin binding by the vanilloid receptor: species-related differences, effects of temperature and sulfhydryl reagents, Naunyn-Schmied. Arch. Pharmacol. 347, 84.
31. 1-acid glycoprotein (orosomucoid) as a major vanilloid-binding protein in serum, J. Pharmacol. Exp. Ther. 262, 883.
32. Szallasi, A., N.E. Lewin and P.M. Blumberg, 1993, Vanilloid (capsaicin) receptor in the rat: positive cooperativity of resiniferatoxin binding and modulation by reduction and oxidation, J. Pharmacol. Exp. Ther. 266, 678
33. 3H]resiniferatoxin autoradiography, Brain Res. 655, 237.
34. Szolcsanyi, J., 1984, Capsaicin and neurogenic inflammation: history and early findings, in: Antidromic Vasodilatation and Neurogenic Inflammation, eds. L.A. Chahl, J. Szolcsanyi and F. Lembeck (Akademiai Kiado, Budapest) p. 7.
35. Szolcsanyi, J., 1991, Perspectives of capsaicin-type agents in pain therapy and research, in: Contemporary Issues in Chronic Pain Management, ed. W.C.V. Parris (Kluwer, Boston) p. 97.
36. Szolcsanyi, J. and A. Jancso-Gabor, 1975, Sensory effects of capsaicin congeners. I. Relationship between chemical structure and pain-producing potency, Drug Res. 25, 1877.
37. Wood, J.N., J. Winter, I.F. James, H.P. Rang, J. Yeats and S. Bevan, 1988, Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture, J. Neurosci. 8, 3208.